What's Causing Adamas Pharmaceuticals to Spike Higher Today
After a leading hedge fund reported it bought shares last month and in the wake of industry watcher upgrades, shares in Adamas Pharmaceuticals (NASDAQ: ADMS) rallied more than 10% higher earlier today.
As fellow Motley Fool Brian Orelli pointed out on October 30, legendary hedge fund guru Steven Cohen recently reported a 5.1% equity stake in Adamas Pharmaceuticals.
IMAGE SOURCE: GETTY IMAGES.
Source: Fool.com
